From: Determinants of quality of life changes with plasmapheresis in patients with myasthenia gravis
 | Control group | TPE group | Test value | P value | Sig. | |
---|---|---|---|---|---|---|
No.= 17 | No.= 81 | |||||
Initial QMG score | Mean ± SD Range | 24.12 ± 2.00 | 25.64 ± 3.95 | −1.547a | 0.125 | NS |
QMG score after 1 month | Mean ± SD Range | 21-27 | 18-34 | 7.818a | 0.001 | HS |
QMG change | Median (IQR) Range | 26.35 ± 3.20 | 18.05 ± 4.12 | −6.404b | 0.001 | HS |
Initial QOL score | Mean ± SD | 43.06 ± 2.66 | 46.47 ± 4.86 | −2.797a | 0.006 | HS |
Range | 38-47 | 36-57 | ||||
QOL score after 1 month | Mean ± SD | 46.12 ± 4.31 | 38.36 ± 6.69 | 4.579a | 0.0001 | HS |
Range | 38-52 | 25-54 | ||||
QOL change | Median (IQR) | 4.76 (0-13.95) | −15.38 (−27.08-−9.09) | −6.091b | 0.0001 | HS |
Range | −5-23.81 | −50-8.16 |